首页> 美国卫生研究院文献>Acta Crystallographica Section F: Structural Biology and Crystallization Communications >Purification crystallization and preliminary X-­ray diffraction studies to near-atomic resolution of dihydrodipicolinate synthase from methicillin-resistant Staphylococcus aureus
【2h】

Purification crystallization and preliminary X-­ray diffraction studies to near-atomic resolution of dihydrodipicolinate synthase from methicillin-resistant Staphylococcus aureus

机译:纯化结晶和初步X射线衍射研究从耐甲氧西林的金黄色葡萄球菌中的二氢二吡啶甲酸合酶的近原子拆分

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In recent years, dihydrodipicolinate synthase (DHDPS; EC 4.2.1.52) has received considerable attention from both mechanistic and structural viewpoints. DHDPS is part of the diaminopimelate pathway leading to lysine, coupling (S)-aspartate-β-semialdehyde with pyruvate via a Schiff base to a conserved active-site lysine. In this paper, the cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of DHDPS from methicillin-resistant Staphylococcus aureus, an important bacterial pathogen, are reported. The enzyme was crystallized in a number of forms, predominantly from PEG precipitants, with the best crystal diffracting to beyond 1.45 Å resolution. The space group was P1 and the unit-cell parameters were a = 65.4, b = 67.6, c = 78.0 Å, α = 90.1, β = 68.9, γ = 72.3°. The crystal volume per protein weight (V M) was 2.34 Å3 Da−1, with an estimated solvent content of 47% for four monomers per asymmetric unit. The structure of the enzyme will help to guide the design of novel therapeutics against the methicillin-resistant S. aureus pathogen.
机译:近年来,从机械和结构的观点来看,二氢二吡啶甲酸合酶(DHDPS; EC 4.2.1.52)受到了相当大的关注。 DHDPS是导致氨基赖氨酸的二氨基庚二酸酯途径的一部分,它通过Schiff碱将(S)-天冬氨酸-β-半醛与丙酮酸偶合到保守的活性位点赖氨酸上。本文报道了耐甲氧西林的金黄色葡萄球菌(一种重要的细菌病原体)中DHDPS的克隆,表达,纯化,结晶和初步X射线衍射分析。该酶以多种形式结晶,主要是从PEG沉淀物中结晶,最好的晶体衍射到超过1.45Å的分辨率。空间群为P1,晶胞参数为a = 65.4,b = 67.6,c = 78.0Å,α= 90.1,β= 68.9,γ= 72.3°。每蛋白质重量的晶体体积(V M)为2.34Å 3 Da -1 ,每个不对称单元的四个单体的估计溶剂含量为47%。该酶的结构将有助于指导针对耐甲氧西林的金黄色葡萄球菌病原体的新型疗法的设计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号